SVShakthi Visagan

Shakthi Visagan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shakthi Visagan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A lineage tree-based hidden Markov model quantifies cellular heterogeneity and plasticity

    by Farnaz Mohammadi, Shakthi Visagan, Sean M. Gross, Luka Karginov, J. C. Lagarde, Laura M. Heiser, Aaron S. Meyer

    Individual cells can assume a variety of molecular and phenotypic states and recent studies indicate that cells can rapidly adapt in response to therapeutic stress. Such phenotypic plasticity may confer resistance, but also presents opportunities to identify molecular programs that could be targeted for therapeutic benefit. Approaches to quantify tumor-drug responses typically focus on snapshot, population-level measurements. While informative, these methods lack lineage and temporal information, which are particularly critical for understanding dynamic processes such as cell state switching. As new technologies have become available to measure lineage relationships, modeling approaches will be needed to identify the forms of cell-to-cell heterogeneity present in these data. Here we apply a lineage tree-based adaptation of a hidden Markov model that employs single cell lineages as input to learn the characteristic patterns of phenotypic heterogeneity and state transitions. In benchmarking studies, we demonstrated that the model successfully classifies cells within experimentally-tractable dataset sizes. As an application, we analyzed experimental measurements in cancer and non-cancer cell populations under various treatments. We find evidence of multiple phenotypically distinct states, with considerable heterogeneity and unique drug responses. In total, this framework allows for the flexible modeling of single cell heterogeneity across lineages to quantify, understand, and control cell state switching.


  • Open Access

    S.M.A.R.T. F.U.S: Surrogate Model of Attenuation and Refraction in Transcranial Focused Ultrasound

    by Joshua A. Cain, Shakthi Visagan, Martin M. Monti

    Low-intensity focused ultrasound (LIFU) is an increasingly applied method for achieving non-invasive brain stimulation. However, transmission of ultrasound through the human skull can substantially affect focal point characteristics of LIFU, including dramatic attenuation in intensity and refraction of focal point location. These effects depend on a high-dimensional parameter space, making these effects difficult to estimate from previous work. Instead, focal point properties of LIFU experiments are often estimated using numerical simulation of LIFU sonication through skull. However, this procedure presents many entry barriers to even computationally savvy investigators and often requires expensive computational hardware, impeding LIFU research. We present a novel MATLAB toolbox (data: doi:10.5068/D1QD60; Matlab Scripts: https://doi.org/10.5281/zenodo.5811122) for rapidly estimating beam properties of LIFU transmitted through bone. Users provide specific values for frequency of LIFU, bone thickness, angle at which LIFU is applied, depth of the LIFU focal point, and diameter of the transducer used and receive an estimation of the degree of refraction/attenuation expected for the given parameters.


  • Open Access

    A lineage tree-based hidden Markov model to quantify cellular heterogeneity and plasticity

    by Farnaz Mohammadi, Shakthi Visagan, Sean M. Gross, Luka Karginov, Jc Lagarde, Laura M. Heiser, Aaron S. Meyer

    Cell plasticity, or the ability of cells within a population to reversibly alter their phenotype, is an important feature of tissue homeostasis during processes such as wound healing and cancer. Plasticity operates alongside other sources of cell-to-cell heterogeneity such as genetic mutations and variation in signaling. Ultimately these processes prevent most cancer therapies from being curative. The predominant methods of quantifying tumor-drug response operate on snapshot population-level measurements and therefore lack evolutionary dynamics, which are particularly critical for dynamic processes such as plasticity. Here we apply a tree-based adaptation of a hidden Markov model (tHMM) that employs single cell lineages as input to learn the characteristic patterns of single cell heterogeneity and state transitions in an unsupervised fashion. This model enables single cell classification based on the phenotype of individual cells and their relatives for improved specificity in pinpointing the structure and dynamics of variability in drug response. Integrating this model with a modular interface for defining observed phenotypes allows the model to easily be adapted to any phenotype measured in single cells. To benchmark our model, we paired cell fate with either cell lifetimes or individual cell cycle phase lengths (G1 and S/G2) as our observed phenotypes on synthetic data and demonstrated that the model successfully classifies cells within experimentally tractable dataset sizes. As an application, we analyzed experimental measurements of cell fate and phase duration in cancer cell populations treated with chemotherapies to determine the number of distinct subpopulations. In total, this tHMM framework allows for the flexible classification of single cell heterogeneity across lineages. Summary points A lineage tree-based hidden Markov model (tHMM) quantifies cell-to-cell variability and dynamic population changes. A modular interface to define phenotypes allows the model to work with any single cell phenotypic measurements. The model accurately classifies cells within experimentally tractable dataset sizes. Classifying cells based on their phenotypic heterogeneity and relationships uncovers dynamics hidden at the population level. Author Summary Heterogeneous traits, such as resistance or susceptibility to a drug, can be correlated in related cells because of shared or inherited factors. These acquired traits may be the result of the microenvironment, epigenetics, or mutations. Using cells’ relationships we capture these dynamic transitions between different cell states and arrive at a more accurate quantification of cell heterogeneity within tumor populations compared to clustering such as K-means that ignores any relationship between the individuals. Our computational approach employing a modified hidden Markov model provides greater specificity by identifying intratumor heterogeneity on a single cell level based on lineage histories and can identify dynamic changes in population structure upon treatment.